233 related articles for article (PubMed ID: 25635584)
21. Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.
Hernàndez S; Morén C; López M; Coll O; Cardellach F; Gratacós E; Miró O; Garrabou G
AIDS; 2012 Feb; 26(4):419-28. PubMed ID: 22156962
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination.
Chan SS; Santos JH; Meyer JN; Mandavilli BS; Cook DL; McCash CL; Kissling GE; Nyska A; Foley JF; van Houten B; Copeland WC; Walker VE; Witt KL; Bishop JB
Environ Mol Mutagen; 2007; 48(3-4):190-200. PubMed ID: 16395692
[TBL] [Abstract][Full Text] [Related]
23. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
Senise JF; Castelo A; Martínez M
AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
[TBL] [Abstract][Full Text] [Related]
24. Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals.
Noguera A; Fortuny C; Muñoz-Almagro C; Sanchez E; Vilaseca MA; Artuch R; Pou J; Jimenez R
Pediatrics; 2004 Nov; 114(5):e598-603. PubMed ID: 15492359
[TBL] [Abstract][Full Text] [Related]
25. Blood mitochondrial DNA mutations in HIV-infected women and their infants exposed to HAART during pregnancy.
Jitratkosol MH; Sattha B; Maan EJ; Gadawski I; Harrigan PR; Forbes JC; Alimenti A; van Schalkwyk J; Money DM; Côté HC;
AIDS; 2012 Mar; 26(6):675-83. PubMed ID: 22436539
[TBL] [Abstract][Full Text] [Related]
26. Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants.
Feiterna-Sperling C; Weizsaecker K; Bührer C; Casteleyn S; Loui A; Schmitz T; Wahn V; Obladen M
J Acquir Immune Defic Syndr; 2007 May; 45(1):43-51. PubMed ID: 17356471
[TBL] [Abstract][Full Text] [Related]
27. Elevated frequencies of micronucleated erythrocytes in infants exposed to zidovudine in utero and postpartum to prevent mother-to-child transmission of HIV.
Witt KL; Cunningham CK; Patterson KB; Kissling GE; Dertinger SD; Livingston E; Bishop JB
Environ Mol Mutagen; 2007; 48(3-4):322-9. PubMed ID: 17358032
[TBL] [Abstract][Full Text] [Related]
28. Perinatal exposure to antiretroviral therapy is associated with increased blood mitochondrial DNA levels and decreased mitochondrial gene expression in infants.
Côté HC; Raboud J; Bitnun A; Alimenti A; Money DM; Maan E; Costei A; Gadawski I; Diong C; Read S; Shen S; Harrigan PR; Burdge DR; King SM; Forbes JC
J Infect Dis; 2008 Sep; 198(6):851-9. PubMed ID: 18684095
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial defects arise from nucleoside/nucleotide reverse transcriptase inhibitors in neurons: Potential contribution to HIV-associated neurocognitive disorders.
Hung KM; Chen PC; Hsieh HC; Calkins MJ
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):406-413. PubMed ID: 27840304
[TBL] [Abstract][Full Text] [Related]
30. Pediatric Neurodevelopmental Functioning After In Utero Exposure to Triple-NRTI vs. Dual-NRTI + PI ART in a Randomized Trial, Botswana.
Kacanek D; Williams PL; Mayondi G; Holding P; Leidner J; Moabi K; Tepper V; Nichols S; Makhema J; Jibril H; Madidimalo T; Shapiro R; Lockman S; Kammerer B
J Acquir Immune Defic Syndr; 2018 Nov; 79(3):e93-e100. PubMed ID: 30015793
[TBL] [Abstract][Full Text] [Related]
31. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
32. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy.
Nolan D; Hammond E; Martin A; Taylor L; Herrmann S; McKinnon E; Metcalf C; Latham B; Mallal S
AIDS; 2003 Jun; 17(9):1329-38. PubMed ID: 12799554
[TBL] [Abstract][Full Text] [Related]
33. Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitors.
Reiss P; Casula M; de Ronde A; Weverling GJ; Goudsmit J; Lange JM
HIV Med; 2004 Jan; 5(1):11-4. PubMed ID: 14731163
[TBL] [Abstract][Full Text] [Related]
34. Treating HIV during pregnancy: an update on safety issues.
Watts DH
Drug Saf; 2006; 29(6):467-90. PubMed ID: 16752931
[TBL] [Abstract][Full Text] [Related]
35. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
36. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission.
Briand N; Le Coeur S; Traisathit P; Karnchanamayul V; Hansudewechakul R; Ngampiyasakul C; Bhakeecheep S; Ithisukanan J; Hongsiriwon S; McIntosh K; Lallemant M
Pediatr Infect Dis J; 2006 Apr; 25(4):325-32. PubMed ID: 16567984
[TBL] [Abstract][Full Text] [Related]
37. Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy.
McComsey GA; Kang M; Ross AC; Lebrecht D; Livingston E; Melvin A; Hitti J; Cohn SE; Walker UA;
HIV Clin Trials; 2008; 9(2):126-36. PubMed ID: 18474497
[TBL] [Abstract][Full Text] [Related]
38. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
Thorne C; Newell ML
Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
[TBL] [Abstract][Full Text] [Related]
39. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
[TBL] [Abstract][Full Text] [Related]
40. Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?
Thorne C; Newell ML
Drug Saf; 2007; 30(3):203-13. PubMed ID: 17343429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
